Complement Factor H: Physiology and Pathophysiology

Peter F. Zipfel

doi:10.1055/s-2001-15248

Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 2001; 27(3): 191-200
DOI: 10.1055/s-2001-15248

Complement Factor H: Physiology and Pathophysiology

Peter F. Zipfel

Department of Infectious Biology, Hans-Knoell Institute for Natural Products Research, Jena, Germany

Abstract

ABSTRACT

The human plasma protein factor H, which is a multifunctional, multidomain protein, acts as a central regulator of the complement system. In addition to its complement regulatory activities, factor H has multiple physiological activities and 1) acts as an extracellular matrix component, 2) binds to cellular receptors of the integrin type, and 3) interacts with a wide selection of ligands, such as the C-reactive protein, thrombospondin, bone sialoprotein, osteopontin, and heparin. Recent genetic reports, which show involvement of factor H in the human disease hemolytic-uremic syndrome (HUS), have attracted the attention of both clinicians and basic complement researchers to the role of factor H in the pathophysiology of HUS.

KEYWORD

Hemolytic-uremic syndrome - HUS - complement system - complement factor H - physiological functions of factor H

Volltext

Referenzen

REFERENCES

1 Kaplan B S, Chesney R W, Drummond K N. Hemolytic uremic syndrome in families. N Engl J Med . 1975; 292 1090-1093
2 Remuzzi G, Ruggenenti P, Bertani T. Thrombotic microangiopathy. In: Tisher CC, Brenner BM, eds. Renal Pathology with Clinical and Functional Correlations Philadelphia: JB Lippincott 1994: 1154-1161
3 Thompson R A, Winterborn M H. Hypocomplementaemia due to a genetic deficiency of β1H globulin. Clin Exp Immunol . 1981; 46 110-119
4 Pichette V, Querin S, Schürch W. Familial hemolytic-uremic syndrome and homozygous factor H deficiency. Am J Kidney Dis . 1994; 26 936-941
5 Warwicker P, Goodship T HJ, Donne R L. Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int . 1998; 53 836-844
6 Noris M, Ruggenenti P, Perna A. Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. J Am Soc Nephrol . 1999; 10 281-293
7 Prodinger W M, Hellwage J, Spruth M, Dierich M P, Zipfel P F. The C-terminus of factor-H: monoclonal antibodies inhibit heparin binding and identify epitopes common to factor H and factor H-related proteins. Biochem J . 1998; 331 41-47
8 Jokiranta T S, Hellwage J, Koistinen V, Zipfel P F, Meri S. Each of the three binding sites on complement factor H interacts with a distinct site on C3b. J Biol Chem . 2000; 275 27657-27662
9 Manuelian T, Brandt E, Oppermann, M, Götze O, Zipfel P F. Manuscript in preparation.
10 Nilsson U R, Müller-Eberhard H. Isolation of b1F-globulin from human serum and its characterization as the fifth component of complement. J Exp Med . 1965; 122 277-282
11 Pangburn M K, Schreiber R D, Müller-Eberhard H J. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein β1H for cleavage of C3b and C4b in solution. J Exp Med . 1977; 146 247-270
12 Whaley K, Ruddy S. Molulation of the alternative complement pathway by β1H globulin. J Exp Med . 1976; 144 1147-1163
13 Vik D P, Munoz-Canoves P, Chaplin D D, Tack B F. Factor H. Curr Top Microbiol Immunol . 1990; 153 147-162
14 Friese M A, Hellwage J, Jokiranta T S. Different regulation of factor H and FHL-1/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA). Clin Exp Immunol . 2000; 121 406-415
15 Lambris J D, Ross G D. Characterization of the lymphocyte membrane receptor for factor H (beta1H-globulin) with an antibody to anti-factor H idiotype. J Exp Med . 1982; 155 1400-1411
16 Avery V M, Gordon D L. Characterization of factor H binding to human polymorphonuclear leukocytes. J Immunol . 1993; 151 5545-5553
17 DiScipio R G, Daffern P J, Schraufstatter I U, Sriramarao P. Human polymorphonuclear leukocytes adhere to complement factor H through an interaction that involves alphaMbeta2 (CD11b/CD18). J Immunol . 1998; 160 4057-4066
18 Nabil K, Rihn B, Jaurand M C. Identification of human complement factor H as a chemotactic protein for monocytes. Biochem J . 1997; 326 377-383
19 Meri S, Pangburn M K. Discrimination between activator and nonactivators of the alternative pathway of complement: regulation via sialic acid/polyanion binding sites on factor H. Proc Natl Acad Sci USA . 1990; 87 3982-3986
20 Carron J A, Bates R C, Smith A I. Factor H co-purifies with thrombospondin isolated from platelet secretate. Biochim Biophys Acta . 1996; 1289 305-311
21 Jarva H, Jokiranta T S, Hellwage J, Zipfel P F, Meri S. Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11. J Immunol . 1999; 163 3957-3962
22 Fedarko N S, Fohr B, Robey P G, Young M F, Fisher L W. Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack. J Biol Chem . 2000; 275 16666-16672
23 Zipfel P F, Hellwage J, Friese M A. Factor H and disease: a complement regulator affects vital body functions. Mol Immunol . 1999; 36 241-248
24 Lindahl G, Sjobring U, Johnsson E. Human complement regulators: a major target for pathogenic microorganisms. Curr Opin Immunol . 2000; 12 44-51
25 Zipfel P F, Skerka C. FHL-1/reconectin: a human complement and immune regulator with cell-adhesive function. Immunol Today . 1999; 20 135-140
26 Zipfel P F, Jokiranta T S, Hellwage J, Koistinen V, Meri S. The factor H protein family. Immunopharmacology . 1999; 42 53-60
27 Male D A, Ormsby R J, Ranganathan S, Giannakis E, Gordon D L. Complement factor H: sequence analysis of 221 kb of human genomic DNA containing the entire fH, fHR-1 and fHR-3 genes. Mol Immunol . 2000; 37 41-52
28 Zipfel P F, Skerka C. Complement factor H and related proteins: an expanding family of complement-regulatory proteins?. Immunol Today . 1994; 15 121-126
29 Hellwage J, Jokiranta T S, Koistinen V. Functional properties of complement factor H-related proteins FHR-3 and FHR-4: binding to the C3d region of C3b and differential regulation by heparin. FEBS Lett . 1999; 462 345-352
30 Gordon D L, Kaufman R M, Blackmore T K, Kwong J, Lublin D M. Identification of complement regulatory domains in human factor H. J Immunol . 1995; 155 348-356
31 Kuhn S, Skerka C, Zipfel P F. Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1. J Immunol . 1995; 155 5663-5670
32 Kuhn S, Zipfel P F. Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H. Eur J Immunol . 1996; 26 2383-2387
33 Sharma A K, Pangburn M K. Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proc Natl Acad Sci USA . 1996; 93 10996-11001
34 Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H. J Immunol . 1996; 157 5422-5427
35 Blackmore T K, Hellwage J, Sadlon T A. Identification of the second heparin-binding domain in human complement factor H. J Immunol . 1998; 160 3342-33348
36 Pangburn M K, Atkinson M A, Meri S. Localization of the heparin-binding site on complement factor H. J Biol Chem . 1991; 266 16847-16853
37 DiScipio R. Ultrastructures and interactions of complement factor H and I. J Immunol . 1989; 149 2592-2599
38 Högasen K, Jansen J H, Mollnes T E, Hovdenes J, Harboe M. Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency. J Clin Invest . 1995; 95 1054-1061
39 Ault B H, Schmidt B Z, Fowler N L. Human factor H deficiency: mutations in framework cysteine residues block H protein secretion and intracellular catabolism. J Biol Chem . 1997; 272 25168-25175
40 Meri S, Koistinen V, Miettinen A, Törnroth T, Seppälä I JT. Activation of the alternative pathway of complement by monoclonal light chains in membranoproliferative glomerulonephritis. J Exp Med . 1992; 175 939-950
41 Jokiranta S T, Solomon A, Pangburn M K, Zipfel P F, Meri S. Nephritogenic lambda-light chain dimer: a unique human miniautoantibody against complement factor H. J Immunol . 1999; 163 4590-4596
42 Schmidt B Z, Fowler N L, Hidvegi T, Perlmutter D H, Colten H R. Disruption of disulfide bonds is responsible for impaired secretion in human complement factor H deficiency. J Biol Chem . 1999; 274 11782-11788
43 Kotarsky H, Hellwage J, Johnsson E. Identification of a domain in human factor H and factor H-like protein-1 required for the interaction with streptococcal M proteins. J Immunol . 1998; 160 3349-3354
44 Kraiczy P, Skerka C, Kirschfink M, Brade V, Zipfel P F. Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and factor H. Europ J Immunol (in press).
45 Ram S, McQuillen D P, Gulati S. Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae J Exp Med . 1998; 188 671-680
46 China B, Sory M P, N'Guyen B T, De Bruyere M, Cornelis G R. Role of the YadA protein in prevention of opsonization of Yersinia enterocolitica by C3b molecules. Infect Immun . 1993; 61 3129-3136
47 Diaz A, Ferreira A, Sim R B. Complement evasion by Echinococcus granulosus: sequestration of host factor H in the hydatid cyst wall. J Immunol . 1997; 158 3779-3786
48 Meri T, Zipfel P F, Meri S. manuscript submitted.
49 Stoiber H, Pinter C, Siccardi A G, Clivio A, Dierich M P. Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF,CD55). J Exp Med . 1996; 183 307-310
50 Johnsson E, Berggard K, Kotarsky H. Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor. J Immunol . 1998; 161 4894-4901
51 Ram S, Sharma A K, Simpson S D. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae J Exp Med . 1998; 187 743-752
52 Junnikkala S, Jokiranta S T, Friese M A. Resistance of human H2 glioblastoma cells to complement-mediated killing by expression and utilization of factor H and factor H-like protein 1. J Immunol . 2000; 164 6075-6081
53 Gorter A, Meri S. Immune evasion of tumor cells using membrane-bound complement regulatory proteins. Immunol Today . 2000; 20 576-582
54 Kinders R, Jones T, Root R. Complement factor H or a related protein is a marker for transitional cell cancer of the bladder. Clin Cancer Res . 1998; 4 2511-2520
55 Bogdanovic R, Cvoric A, Nikolic V, Sindjic M. Recurrent haemolytic-uraemic syndrome with hypocomplementaemia: a case report. Pediatr Nephrol . 1988; 2 236-238
56 Carreras L, Romero R, Requesens C. Familial hypocomplementemic hemolytic uremic syndrome with HLA-A3,B7 haplotype. JAMA . 1981; 245 602-604
57 Ohali M, Shalev H, Schlesinger M. Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H. Pediatr Nephrol . 1998; 12 619-624
58 Rougier N, Kazatchkine M D, Rougier J P. Human complement factor H deficiency associated with hemolytic uremic syndrome. J Am Soc Nephrol . 1998; 9 2318-2326
59 Hourcade D, Garcia A D, Post T W. Analysis of the human regulators of complement activation (RCA) gene cluster with yeast artificial chromosomes (YACs). Genomics . 1992; 12 289-300
60 Caprioli J, Bettingalio P, Zipfel P F. Mutations of factor H (HF) in familial hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP). J Am Soc Nephrol . 2001; 12 297-307
61 Buddels M RH, Donne R L, Richards A, Goodship J, Goodship THJ.Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome (Letter). Am J Genet . 2000; 66 1721-1722
62 Ying L, Katz Y, Schlesinger M. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome. Am J Hum Genet . 1999; 65 1538-1546